|
Novartis receives regulatory approval in Germany for Celtura®, a cell culture-based Influenza A(H1N1) pandemic vaccine
http://www.novartis.com/newsroom/media-r... They are also opening up a cell base manufacturing plant next month in the US. Anyone have any thoughts?? Sanofi Pasteur seems to be needing to catch up fast. I wonder if they have their own thing going or do they need to buy nvax to compete. They were under heat for only delivering part of the h1n1 they promised. Rating :
 (2 Ratings) |
 |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
Messages in Topic
| Subject | Author | Rating | Time of Post (ET) | ||
|---|---|---|---|---|---|
|
novartis
|
wilhelminas... | (2 Ratings) | 8-Nov-09 01:21 am | ||
|
500 million and 5 years to build. They missed this...
|
majaver26 | (1 Rating) | 8-Nov-09 09:20 am | ||
|
maja.. the HHS first gave Novartis 200 millio...
|
rezoom24 |
 
|
8-Nov-09 09:49 am | ||
|
"Our modern cell culture technology can enabl...
|
sz5658 | Rate it | 8-Nov-09 09:56 am | ||
|
sz. ... you have your wires crossed... j...
|
rezoom24 | Rate it | 8-Nov-09 10:04 am |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
0.05